Loading…
Loading…
RYJ (Invesco Raymond James SB-1 Equity ETF) is no longer actively trading.
This usually means the fund has been liquidated, merged into another product, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, the index provider compiles, maintains, and calculates the underlying index, which is comprised of U.S.-listed equity securities that are rated Strong Buy 1 ("SB-1") by an affiliate of the index provider.
Is RYJ's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
During the shortened trading week leading up to the Easter holiday, a total of 10 new ETFs launched on the U.S. market. These include funds from BlackRock, Morgan Stanley, VanEck, Invesco, Eagle Capital and Inspire.
The last full week of the year was a busy one, with 18 new ETFs launching. Among the rolled-out funds were offerings from Texas Capital, PlanRock, PGIM, John Hancock, SP Funds, Bancreek, KB Asset Management, ProShares, and WisdomTree.
With only four trading days during the week, ETF launches were few and far between. Only four new funds launched this week.
RYJ is a passively managed fund with an active ingredient beneath the surface. Stocks that have been added since the previous coverage in May now account for almost 15%. Factor exposure has mostly deteriorated, including on the valuation, quality, and growth fronts. The fund has surprised to the upside in the summer, which still changes nothing fundamentally about my overall skepticism.
I would like to provide the sentiment update on RYJ, a quasi-actively managed fairly expensive high-turnover fund I previously covered in March, with an overall skeptical tone. Despite meaningful changes in the mix and the fact that RYJ has underperformed the S&P 500 by ~12% since previous coverage, there is no reason to upgrade it.